Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Burris

Showing results (31-40 of 114) with videos related to

Pageof 12
Sort By:
Anti-Cancer Drugs|April 1, 1994
Activity of CPT-11 (irinotecan hydrochloride), a topoisomerase I inhibitor, against human tumor colony-forming unitsY Shimada, M Rothenberg, S G Hilsenbeck, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
New anticancer agentsG R Weiss, H A Burris, S G Eckhardt, et al.
Cancer|December 18, 2001
Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research NetworkJ D Hainsworth, H A Burris, F T Billings, et al.
Cancer Journal (Sudbury, Mass.)|June 23, 2001
Taxane-based chemotherapy for patients with carcinoma of unknown primary siteF A Greco, J Gray, H A Burris, et al.
Journal of the National Cancer Institute|April 6, 1994
Prevention of docetaxel-induced erythrodysesthesia with local hypothermiaG C Zimmerman, J H Keeling, M Lowry, et al.
Cancer|August 16, 2001
Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas: results of a Phase II trialJ D Hainsworth, H A Burris, A A Meluch, et al.
Anti-Cancer Drugs|February 1, 1993
Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancerD A Rinaldi, S M Lippman, H A Burris, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
New anticancer agentsG R Weiss, H A Burris, J R Eckardt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Preclinical and phase I trials of topoisomerase I inhibitorsD D Von Hoff, H A Burris, J Eckardt, et al.
Cancer|March 16, 2000
Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: a minnie pearl cancer research network phase II trialJ D Hainsworth, H A Burris, S Litchy, et al.
Pageof 12

Showing results (31-40 of 114) with videos related to

Sort By:
Pageof 12
Anti-Cancer Drugs|April 1, 1994
Activity of CPT-11 (irinotecan hydrochloride), a topoisomerase I inhibitor, against human tumor colony-forming unitsY Shimada, M Rothenberg, S G Hilsenbeck, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1997
New anticancer agentsG R Weiss, H A Burris, S G Eckhardt, et al.
Cancer|December 18, 2001
Weekly docetaxel with either gemcitabine or vinorelbine as second-line treatment in patients with advanced nonsmall cell lung carcinoma: Phase II trials of the Minnie Pearl Cancer Research NetworkJ D Hainsworth, H A Burris, F T Billings, et al.
Cancer Journal (Sudbury, Mass.)|June 23, 2001
Taxane-based chemotherapy for patients with carcinoma of unknown primary siteF A Greco, J Gray, H A Burris, et al.
Journal of the National Cancer Institute|April 6, 1994
Prevention of docetaxel-induced erythrodysesthesia with local hypothermiaG C Zimmerman, J H Keeling, M Lowry, et al.
Cancer|August 16, 2001
Paclitaxel, carboplatin, and long-term continuous infusion of 5-fluorouracil in the treatment of advanced squamous and other selected carcinomas: results of a Phase II trialJ D Hainsworth, H A Burris, A A Meluch, et al.
Anti-Cancer Drugs|February 1, 1993
Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancerD A Rinaldi, S M Lippman, H A Burris, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1994
New anticancer agentsG R Weiss, H A Burris, J R Eckardt, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Preclinical and phase I trials of topoisomerase I inhibitorsD D Von Hoff, H A Burris, J Eckardt, et al.
Cancer|March 16, 2000
Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: a minnie pearl cancer research network phase II trialJ D Hainsworth, H A Burris, S Litchy, et al.
Pageof 12